About the Company
Fresenius Kabi Oncology Limited is a public company primarily operating in the field of Research & Development and manufacturing of world-class oncology drugs. The company strives to provide state-of-the-art third generation chemotherapeutic drugs right from development to manufacturing & marketing across the globe. It is fast emerging as a leading player in oncology generics on the strength of its comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and Active Pharmaceutical Ingredients (APIs).
Fresenius Kabi Oncology is the subsidiary of Fresenius Kabi AG, Germany. Fresenius Kabi Oncology specializes in the manufacturing of anti-cancer (oncology) drugs to treat chronically and critically ill cancer patients. As a part of the globally reputed Fresenius Healthcare Group, it plays a pivotal role in patient care, both within and outside hospitals, to efficaciously carry forward its mission of “caring for life”.
The company has two manufacturing plants. The first is in Himachal Pradesh and the second is in West-Bengal.
Industry Analysis
According to a market report, the global cancer therapy market was valued at 9.53 lakh cr in 2018 and estimated to be valued at 15.44 lakh cr by 2024, witnessing a CAGR growth of 8.37%.
Cancer therapy is a highly competitive market, consists of several major players who dominate the market. With the use of technology, a lot of mid and small-sized companies are giving very good competition at a very attractive price.
Indian Drugs are exported to more than 200 countries around the world and the USA is the key market. Approximately 30% of the drugs exported to the USA in 2018.
Total Available Shares: | 1000 |
Face Value: | ₹ 1 Per Equity Share |
ISIN: | INE575G01010 |
Retail Discount: | Bulk Deal (1%) |
Year | Revenue | EBITDA | OPM | PAT | NPM | Equity | EPS |
2018 | 701 | 158 | 23% | 19.38 | 3% | 1.702 | 1.13 |
2019 | 734 | 131 | 18% | -53.92 | -7% | 1.702 | -3.17 |
Please find below the procedure for buying Fresenius Kabi Oncology Unlisted Shares at UnlistedZone.
Please find below the procedure for selling Fresenius Kabi Oncology Unlisted Shares at UnlistedZone.
Lock-in period of Fresenius Kabi Oncology Unlisted Shares depends upon category of investors.
DIS - Delivery Instruction Slip is the way through which an investor can sell or transfer the Fresenius Kabi Oncology Unlisted Shares from his/her demat account to any other demat account. There are two Types of DIS Slip.
In the last 4-5 years, the unlisted share market has become quite big and as a result of that, the ticket size has reduced from usual 5-10 Lac to 35-50k in today's scenario. So, via our UnlistedZone platform, if somebody wants to buy Fresenius Kabi Oncology Unlisted Shares then minimum investment would be 35-50k.
Yes, buying and selling of unlisted shares in India is 100% legal.
If you sell your shares within 2 years, then you will have to pay Short-term Capital gain on unlisted shares. Short-Term Capital Gain is added in your Income. So, as per individual tax slab you need to pay capital gain tax.
If you sell your shares after 2 years, then you will have to pay Long-term Capital gain on unlisted shares LTCG is 20% with indexation benefits.
After listing of shares, the unlisted shares which you have bought through unlisted market, will be taxed at listed rates, if sold through exchange. So, taxes of listed market will be applicable. And, to calculate holding time, for determining LTCG or STCG, the purchase date of unlisted shares will be applicable.
If you buy Fresenius Kabi Oncology Unlisted Shares from UnlistedZone then these shares can checked in two ways. However, before we tell you the process of checking of shares, it is intimated that as per SEBI regulations, the shares can be transferred in demat account only.
Check credit of Fresenius Kabi Oncology Unlisted Shares Instantly?
The Fresenius Kabi Oncology Unlisted Shares are credited in demat account same day of transferring funds in our company's bank account.
The price of Fresenius Kabi Oncology Unlisted Shares can be checked in two ways. First, you can join our telegram channel where on daily basis we share the latest prices of all the unlisted shares in the morning and secondly, you can register on UnlistedZone.live platform to see the historical graphs and prices of all the shares at one place.
If you see the thesis of investment in the unlisted shares then it is being done mainly to take the advantage of IPO market. And, if the IPO plans of company get delayed due to market conditions or any other reason then demand suddenly drops in the market. The unlisted market works mainly on demand and supply and if there is no IPO news then getting exit would be difficult.
"UnlistedZone is India's fastest and leading marketplace to buy and sell unlisted shares. In the last 3 years, we have already served more than 1 million users on the platform. The total transactions value done from the platform is already more than 100 Crores. The name of our Co-founders Mr. Umesh Paliwal and Dinesh Gupta publish regularly in leading newspapers like MoneyControl, Business-Standard, ET etc for their views on IPO and Unlisted market. In the last 3 years, UnlistedZone has made a good name for itself in the industry and gained a trust of their users. So, the new investors should not be worried about any kind of fraud that is mostly happens with unkown brokers in the market while doing investment with UnlistedZone."
We at UnlistedZone do the valuation based on 2 methods.
As an investor in the unlisted space, we would always recommend that you must check all the risk parameter carefully before investing in the unlisted space.
We source shares either from the employees or initial investors looking to liquidate their Fresenius Kabi Oncology Unlisted Shares.
Pre-IPO shares means which are planning for an IPO in near future. So, all the shares which are traded on the platform are not Pre-IPO Shares. However, if the company's business is going good and then demand will always be there in the unlisted space, so even if the IPO does not come, the investors can easily liquidate their Fresenius Kabi Oncology Unlisted Shares in the unlisted market itself.
Rules and regulations of SEBI are applicable in the Unlisted space like lock-in period of 6 months, paying of Stamp Duty, and DP Charges for every transaction etc. However, to become an unlisted broker there is no such regulation by SEBI as of yet.
For tracking news and other information about Fresenius Kabi Oncology Unlisted Shares, one can visit our website wherein we post news and other information on daily basis and one can also join our telegram channel.
You must be logged in to post a comment.
Market Wizard
Important information for the shareholders:
1. Fresenius Kabi Oncology in the year 2018 has filed a case in NCLT for capital reduction.
They have proposed to reduce the number of shares from 17,02,47,857 equity shares of INR 1 (Indian rupee one) to 16,52,32,882 equity shares of INR 1 (Indian rupee one) each by canceling and extinguishing in the aggregate, approximately 2.95% (two point nine five percent) of the total issued, subscribed and paid-up share capital of the Company, consisting of 50,14,975.
2. As per the annual report 2018-19, total shares held by promoters were 97.05% and minority shareholders were 2.95%.
3. So, the company has given exit to the minority shareholders by paying Rs. 58.40 per share in lieu of their shares being extinguished in accordance with the Order.
Resident Shareholders:
The company will pay the amount after deducting 7.5% TDS to the eligible shareholders.
Non- Resident Shareholders:
The company will pay the amount after deducting 20% TDS to the eligible shareholders.